B
Evidence Grade B
Graded
under review
Safe to Cite
Current
$8,800,000
$8,800,000 -- quarterly revenue for X4 Pharmaceuticals (Q2 2026)
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
$8,800,000
Unit
Currency Usd
Data Vintage
Q2 2026
Entity
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
95
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
The Associated Press
Primary
Tier A
https://wtop.com/news/2026/08/x4-pharmaceuticals-q2-earnings-snapshot/ ↗
Source Article
X4 Pharmaceuticals: Q2 Earnings Snapshot
Original Research
The Associated Press
· Original study ↗
Methodology
Company earnings report
Methodology documented
Segmentation
Industrymarketing
Cite this stat
Plain Text
X4 Pharmaceuticals: $8,800,000 quarterly revenue. Source: The Associated Press (Q2 2026). Via Lighthouse Intelligence -- https://lighthousedata.io/data/x4-pharmaceuticals-q2-revenue
HTML Embed
<blockquote cite="https://lighthousedata.io/data/x4-pharmaceuticals-q2-revenue" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>$8,800,000</strong> -- quarterly revenue for X4 Pharmaceuticals<br><small>Source: The Associated Press (Q2 2026) · <a href="https://lighthousedata.io/data/x4-pharmaceuticals-q2-revenue" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Related Statistics
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.